TrialLancet (London, England)2020

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.

Yeming Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.